These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15228494)

  • 41. Diagnostic and management challenges for childhood tuberculosis in the era of HIV.
    Marais BJ; Graham SM; Cotton MF; Beyers N
    J Infect Dis; 2007 Aug; 196 Suppl 1():S76-85. PubMed ID: 17624829
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Promising drugs against tuberculosis.
    de Souza MV
    Recent Pat Antiinfect Drug Discov; 2006 Jan; 1(1):33-44. PubMed ID: 18221132
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New old challenges in tuberculosis: potentially effective nanotechnologies in drug delivery.
    Sosnik A; Carcaboso AM; Glisoni RJ; Moretton MA; Chiappetta DA
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):547-59. PubMed ID: 19914315
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current development and future prospects in chemotherapy of tuberculosis.
    Nuermberger EL; Spigelman MK; Yew WW
    Respirology; 2010 Jul; 15(5):764-78. PubMed ID: 20546189
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prospects for new antitubercular drugs.
    Duncan K; Barry CE
    Curr Opin Microbiol; 2004 Oct; 7(5):460-5. PubMed ID: 15451500
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prospects for advancing tuberculosis control efforts through novel therapies.
    Salomon JA; Lloyd-Smith JO; Getz WM; Resch S; Sánchez MS; Porco TC; Borgdorff MW
    PLoS Med; 2006 Aug; 3(8):e273. PubMed ID: 16866578
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New tuberculosis therapy offers potential shorter treatment.
    Wkly Epidemiol Rec; 2006 Jan; 81(2):19-20. PubMed ID: 16671244
    [No Abstract]   [Full Text] [Related]  

  • 48. Tuberculosis: the drug development pipeline at a glance.
    Villemagne B; Crauste C; Flipo M; Baulard AR; Déprez B; Willand N
    Eur J Med Chem; 2012 May; 51():1-16. PubMed ID: 22421275
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhaled drug therapy for treatment of tuberculosis.
    Misra A; Hickey AJ; Rossi C; Borchard G; Terada H; Makino K; Fourie PB; Colombo P
    Tuberculosis (Edinb); 2011 Jan; 91(1):71-81. PubMed ID: 20875771
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tuberculosis drug discovery and emerging targets.
    Mdluli K; Kaneko T; Upton A
    Ann N Y Acad Sci; 2014 Sep; 1323():56-75. PubMed ID: 24920100
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Therapy in tuberculosis].
    Somoskövi A; Lantos A
    Orv Hetil; 2004 Apr; 145(16):871-3. PubMed ID: 15156693
    [No Abstract]   [Full Text] [Related]  

  • 52. [Tuberculosis - historical development, current status, future prospects].
    Loddenkemper R; Diel R; Schaberg T
    Pneumologie; 2010 Sep; 64(9):567-72. PubMed ID: 20827640
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New tuberculosis therapy offers potential shorter treatment. Phase III trials planned in Africa.
    Saudi Med J; 2006 Apr; 27(4):573-4. PubMed ID: 16736564
    [No Abstract]   [Full Text] [Related]  

  • 54. Rifapentine--a long-acting rifamycin for tuberculosis.
    Med Lett Drugs Ther; 1999 Feb; 41(1047):21-2. PubMed ID: 10076594
    [No Abstract]   [Full Text] [Related]  

  • 55. TB treatment evolves.
    Huff B
    GMHC Treat Issues; 2003 Oct; 17(10):4-5. PubMed ID: 14689926
    [No Abstract]   [Full Text] [Related]  

  • 56. Does the use of fluoroquinolones for the empiric treatment of pneumonia delay initiation of treatment of tuberculosis?
    Abiad H
    Clin Infect Dis; 2002 Dec; 35(12):1572; author reply 1572-3. PubMed ID: 12471582
    [No Abstract]   [Full Text] [Related]  

  • 57. Tuberculosis in Africa: learning from pathogenesis for biomarker identification.
    Kaufmann SH; Parida SK
    Cell Host Microbe; 2008 Sep; 4(3):219-28. PubMed ID: 18779048
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Shortening treatment of tuberculosis: lessons from fluoroquinolone trials.
    Nimmo C; Lipman M; Phillips PP; McHugh T; Nunn A; Abubakar I
    Lancet Infect Dis; 2015 Feb; 15(2):141-3. PubMed ID: 25749057
    [No Abstract]   [Full Text] [Related]  

  • 59. Tuberculosis in Africa: clinical presentation and management.
    Harries AD
    Pharmacol Ther; 1997; 73(1):1-50. PubMed ID: 9014205
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tuberculosis drug targets.
    Zhang Y; Amzel LM
    Curr Drug Targets; 2002 Apr; 3(2):131-54. PubMed ID: 11958297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.